Skip to Content

LL 35 (Endacof tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg)

Generic Name: guaifenesin/hydrocodone

Pill imprint LL 35 has been identified as Endacof tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg.

EndaCof-Tab is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. EndaCof-Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Endacof tab
Generic Name:
guaifenesin/hydrocodone
Imprint:
LL 35
Strength:
guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Larken Laboratories, Inc.

More info Print Imprint Search

More about EndaCof-Tab (guaifenesin / hydrocodone)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide